1.De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review.
Hanxu GUO ; Chengqi JIN ; Li DING ; Jun XIE ; Jing XU ; Ruiliang WANG ; Hong WANG ; Changcheng GUO ; Jiansheng ZHANG ; Bo PENG ; Xudong YAO ; Jing YUAN ; Bin YANG
Chinese Medical Journal 2025;138(2):231-233
2.Effect of interventional chemotherapy on the expression of vascular endothelial growth factor and microvessel density in rectal carcinoma
Bingsheng WANG ; Zhengwen XIONG ; Xiufang LIU ; Ruiliang DING ; Zenghu ZHAO ; Chengyun LI ; Hai ZHANG
Chinese Journal of General Surgery 2000;0(11):-
ObjectiveTo evaluate the effect of interventional chemotherapy (ICT)on the expression of vascular endothelial growth factor(VEGF) and microvessel density (MVD) in rectal carcinoma.MethodsThe expression of VEGF and MVD in 34 patients of rectal cancer were determined before the ICT and 4～5 weeks after the ICT. ResultsBefore the ICT and 4～5 week after the ICT, the expressions of VEGF in the tissue of rectal cancer was 61.8%(21/34) and 32.3%(11/34) respectively(P
Result Analysis
Print
Save
E-mail